Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

Researchers at Karolinska Institutet have identified a mechanism responsible for a serious psychiatric complication caused by ...

Health service announces three-year safety improvement programme to ensure patients receive critical medicine on time ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

New research suggests that a novel drug molecule could lead to treatments preventing Parkinson’s disease in younger patients.